Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1966;34(4):533–551.

A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS*

J J Y Dawson, S Devadatta, Wallace Fox, S Radhakrishna, C V Ramakrishnan, P R Somasundaram, H Stott, S P Tripathy, S Velu
PMCID: PMC2475991  PMID: 5296380

Abstract

This report from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress over a 5-year period of 193 patients with newly diagnosed, sputum-positive pulmonary tuberculosis who were admitted to a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS. Previous reports have shown that, despite the traditional advantages of sanatorium treatment—rest, adequate diet, nursing and supervised drug-administration—the home patients responded nearly as well as the sanatorium patients in the first year; further, the relapse rates over a 2-year period of follow-up were similar. The findings in the present report are based on a 4-year period of follow-up and extend these conclusions, the relapse rates over the period being 7% for the home patients and 10% for the sanatorium patients.

Patients who failed to respond to treatment in the first year and those who had a bacteriological relapse in the second or subsequent years were usually re-treated with reserve regimens, first with streptomycin plus pyrazinamide and, if this was ineffective, with cycloserine plus ethionamide. Considering the findings over the entire 5-year period, five home patients and three sanatorium patients died from non-tuberculous causes. Of the remainder, 5% of the home patients and 6% of the sanatorium patients died of tuberculosis, 4% in each series had bacteriologically active disease at five years and 90% and 89%, respectively, had bacteriologically quiescent disease at that time. These findings are very encouraging, particularly for developing countries such as India, where tuberculosis is a major problem and sanatorium beds are very few.

Full text

PDF
533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDREWS R. H., DEVADATTA S., FOX W., RADHAKRISHNA S., RAMAKRISHNAN C. V., VELU S. Prevalence of tuberculosis among close family contacts of tuberculous patients in South India, and influence of segregation of the patient on early attack rate. Bull World Health Organ. 1960;23:463–510. [PMC free article] [PubMed] [Google Scholar]
  2. ANGEL J. H., BHATIA A. L., DEVADATTA S., FOX W., JANARDHANAM B., RADHAKRISHNA S., RAMAKRISHNAN C. V., SELKON J. B., STOTT H., VELU S. A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy. Tubercle. 1963 Jun;44:215–224. doi: 10.1016/s0041-3879(63)80115-4. [DOI] [PubMed] [Google Scholar]
  3. DEVADATTA S., ANDREWS R. H., ANGEL J. H., BHATIA A. L., FOX W., JANARDHANAM B., RADHAKRISHNA S., RAMAKRISHNAN C. V., SUBBAIAH T. V., VELU S. Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate. Bull World Health Organ. 1961;24:149–175. [PMC free article] [PubMed] [Google Scholar]
  4. DOONEIEF A. S., HITE K. E., BLOCH R. G. Indefinitely prolonged chemotherapy for tuberculosis; an appeal. AMA Arch Intern Med. 1955 Oct;96(4):470–477. doi: 10.1001/archinte.1955.00250150044004. [DOI] [PubMed] [Google Scholar]
  5. FOX W. REALISTIC CHEMOTHERAPEUTIC POLICIES FOR TUBERCULOSIS IN THE DEVELOPING COUNTRIES. Br Med J. 1964 Jan 18;1(5376):135–142. doi: 10.1136/bmj.1.5376.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kamat S. R., Dawson J. J., Devadatta S., Fox W., Janardhanam B., Radhakrishna S., Ramakrishnan C. V., Somasundaram P. R., Stott H., Velu S. A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull World Health Organ. 1966;34(4):517–532. [PMC free article] [PubMed] [Google Scholar]
  7. RALEIGH J. W. The late results of prolonged multiple-drug therapy for pulmonary tuberculosis. Am Rev Tuberc. 1957 Oct;76(4):540–558. doi: 10.1164/artpd.1957.76.4.540. [DOI] [PubMed] [Google Scholar]
  8. RAMAKRISHNAN C. V., ANDREWS R. H., DEVADATTA S., FOX W., RADHAKRISHNA S., SOMASUNDARAM P. R., VELU S. Influence of segregation to tuberculous patients for one year on the attack rate of tuberculosis in a 2-year period in close family contacts in South India. Bull World Health Organ. 1961;24:129–148. [PMC free article] [PubMed] [Google Scholar]
  9. RAMAKRISHNAN C. V., RAJENDRAN K., JACOB P. G., FOX W., RADHAKRISHNA S. The role of diet in the treatment of pulmonary tuberculosis. An evaluation in a controlled chemotherapy study in home and sanatorium patients in South India. Bull World Health Organ. 1961;25:339–359. [PMC free article] [PubMed] [Google Scholar]
  10. RYDER J. B. Prognosis of persistent cavitation in sputum-negative cases of tuberculosis following long-term chemotherapy. Tubercle. 1958 Apr;39(2):113–115. doi: 10.1016/s0041-3879(58)80029-x. [DOI] [PubMed] [Google Scholar]
  11. Ramakrishnan C. V., Rajendran K., Mohan K., Fox W., Radhakrishna S. The diet, physical activity and accommodation of patients with quiescent pulmonary tuberculosis in a poor South Indian community. A four-year follow-up study. Bull World Health Organ. 1966;34(4):553–571. [PMC free article] [PubMed] [Google Scholar]
  12. VELU S., ANDREWS R. H., ANGEL J. H., DEVADATTA S., FOX W., GANGADHARAM P. R., NARAYANA A. S., RAMAKRISHNAN C. V., SELKON J. B., SOMASUNDARAM P. R. Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate. Bull World Health Organ. 1961;25:409–429. [PMC free article] [PubMed] [Google Scholar]
  13. VELU S., ANDREWS R. H., ANGEL J. H., DEVADATTA S., FOX W., JACOB P. G., NAIR C. N., RAMAKRISHNAN C. V. Streptomycin plus pyrazinamide in the treatment of patients excreting isonazid-resistant tubercle bacilli, following previous chemotherapy. Tubercle. 1961 Jun;42:136–147. doi: 10.1016/s0041-3879(61)80089-5. [DOI] [PubMed] [Google Scholar]
  14. VELU S., ANDREWS R. H., DEVADATTA S., FOX W., RADHAKRISHNA S., RAMAKRISHNAN C. V., SELKON J. B., SOMASUNDARAM P. R., SUBBAIAH T. V. Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate. Bull World Health Organ. 1960;23:511–533. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES